Academisch Ziekenhuis Groningen
Organisation
Trials
Collaborator, Phase 4, Recruiting, 490 people, 13 Feb 2023
Grants and prizes
HORIZON-JU-RIA, EXIT-CVD, 101253160, €2.6m, 2026–2031, Lead, 31 Mar 2026
HORIZON-JU-RIA, Collaborative Action and Research for Engagement, Persistence and Adherence in Treatment & Health, 101192133, €749.6k, 2025–2030, 8 May 2025
ERC-COG, Early detection, molecular mechanisms and therapeutic interventions in chronic kidney disease, 101125516, €2m, 2024–2029, 10 Jul 2024
HORIZON-CSA, TWINNING FOR EXCELLENCE IN RESEARCH, TRAINING AND INNOVATION IN EARLY-IN-LIFE STRESS AND AGING, 101159690, €284.4k, 2024–2027, 9 May 2024
HORIZON-TMA-MSCA-PF-EF, MyoNanoCell: CardioMYOgenic NANOsized CELL-based Vehicles for Cardiac Microenvironment Modulation and Heart Fibrosis Therapy, 101146545, €187.6k, 2025–2027, 8 May 2024
HORIZON-TMA-MSCA-PF-EF, Microfluidics-assisted synthesis of Dapagliflozin-loaded liposomes for heart fibrosis: Development of a 3D bioprinted multicellular in vitro model, 101146615, €187.6k, 2024–2026, 7 Mar 2024
HORIZON-RIA, Unraveling the dark matter of infectious diseases, environmental and genetic factors tipping the balance towards NCDs, 101136582, €851.1k, 2024–2028, 11 Dec 2023
HORIZON-RIA, An Integrated Life-Course Approach for Person-Centred Solutions and Care for Ageing with Multi-morbidity in the European Regions - STAGE; Stay Healthy Through Ageing, 101137146, €911k, 2024–2029, 9 Dec 2023
Sources: cordis.europa.eu